It did not have a significantly different therapeutic efficacy from the commercial paste dosage form in the treatment of oral lichen planus. Buffering agents and an antioxidant should be added to ...

Lipella Pharmaceuticals (LIPO) announced topline results from the second cohort of its Phase 2a multicenter, dose-ranging trial evaluating ...

The post Lipella Reports Additional Positive Data from Phase 2a Trial of LP-310 in Oral Lichen Planus appeared first on PRISM MarketView.

Second Cohort Results Highlight Efficacy Across All Key Measures and Reinforce Safety of Twice-Daily Oral RinsePhase 2a Study Now Fully Enrolled ...

Lipella Pharmaceuticals chief medical officer and co-founder Dr Michael Chancellor said: “The completion of enrollment in our ...

This is known as the isomorphic response or Koebner phenomena. Varients of lichen planus are presented in Figures 2-9. Treatment: There is no cure for lichen planus but treatment often relieves ...

These rough patches can also be itchy. Lichen planus can’t be cured, so treatments focus on managing symptoms. Your doctor can provide a proper diagnosis and work to create a treatment plan that ...

Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing innovative therapies for unmet medical needs, today announced the ...

“Oral lichen planus is a painful, chronic condition with no FDA-approved treatment and limited therapeutic options. The symptom relief reported by patients, along with reductions in inflammation ...

locally delivered treatment for oral lichen planus, an underserved condition with no FDA-approved therapies. “We have already observed encouraging safety and efficacy signals in the first two ...

"Oral lichen planus is a painful, chronic condition with no FDA-approved treatment and limited therapeutic options. The symptom relief reported by patients, along with reductions in inflammation ...